Endometrial-Myometrial Interface: Relationship to Adenomyosis and Changes in Pregnancy
This paper describes the endometrial-myometrial interface, its unique features, its disruption during pregnancy and adenomyosis, and the roles of sex steroids and local mediators.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Full text
2,368 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (56)
- Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium via openalex
- Cell Proliferation and apoptosis: Detection of apoptosis in human endometriotic tissues via openalex
- Characterization of subendometrial myometrial contractions throughout the menstrual cycle in normal fertile women via openalex
- Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues via openalex
- Expression of adhesion molecules in human endometrial vasculature throughout the menstrual cycle via openalex
- Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine via openalex
- Is adenomyosis an immune disease? via openalex
- Localization of T Cells, Interferon-Gamma and HLA-DR in Eutopic and Ectopic Human Endometrium via openalex
- Pathologic Findings from the Maryland Womenʼs Health Study: Practice Patterns in the Diagnosis of Adenomyosis via openalex
- Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma via openalex
- Smooth muscle differentiation at endometrio-myometrial junction via openalex
- The cyclic pattern of the immunocytochemical expression of oestrogen and progesterone receptors in human myometrial and endometrial layers: characterization of the endometrialsubendometrial unit via openalex
- The elusive adenomyosis of the uterus via openalex
- The elusive adenomyosis of the uterus—revisited via openalex
- The nonsurgical diagnosis of adenomyosis via openalex
- The uterus: in vitro MR-anatomic correlation of normal and abnormal specimens. via openalex
- Ultrastructural changes in uterine myometrium of mice with experimentally-induced adenomyosis via openalex
- Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen via openalex
- Uterine junctional zone: function and disease via openalex
- W2073730670 via openalex
- W2090012882 via openalex
- W2093047683 via openalex
- W2106195080 via openalex
- W86461427 via openalex
- W2113276741 via openalex
- W2115081018 via openalex
- W2123034006 via openalex
- W2123139933 via openalex
- W2127155035 via openalex
- W2155334311 via openalex
- W2165109616 via openalex
- W2238091929 via openalex
- W2243809168 via openalex
- W2273333468 via openalex
- W2287485666 via openalex
- W2406102853 via openalex
- W4247344887 via openalex
- W2110548184 via openalex
- W143665051 via openalex
- W1571180753 via openalex
- W1632022789 via openalex
- W1848970261 via openalex
- W1916481231 via openalex
- W1973076537 via openalex
- W1979519933 via openalex
- W1997513963 via openalex
- W1997746787 via openalex
- W2018372782 via openalex
- W2031594566 via openalex
- W2033945601 via openalex
- W2035633938 via openalex
- W2038715249 via openalex
- W2046882427 via openalex
- W2051768735 via openalex
- W2052930528 via openalex
- W2058692557 via openalex
Cited by (50)
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- The Role of M1 and M2 Macrophages in the Progression of Endometrial Hyperplasia to Endometrioid Adenocarcinoma 2025
- Systematic review and meta-analysis of adverse pregnancy outcomes with different types of adenomyosis 2025
- Lipidome atlas of human myometrium reveals distinctive lipid signatures associated with adenomyosis: Combination of high-coverage lipidomics and mass spectrometry imaging 2025
- Analysis of Dysmenorrhea-Related Factors in Adenomyosis and Development of a Risk Prediction Model 2024
- Proliferative characteristics of eutopic and ectopic endometrium in adenomyosis using AgNOR technology 2023
- Histopathological characteristics of adenomyosis: structure and microstructure 2023
- Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome 2023
- Unveiling the Pathogenesis of Adenomyosis through Animal Models 2022
- Integrative metabolomic profiling reveals aberrations in myometrium associated with adenomyosis: a pilot study 2022
- Establishment of a novel mouse model of adenomyosis suitable for longitudinal and quantitative analysis and perinatal outcome studies 2022
- Endometriosis: A Retrospective Analysis of Clinical Data from a Cohort of 4,083 Patients, With Focus on Symptoms 2022
- Establishment of a novel mouse model of adenomyosis suitable for longitudinal and quantitative analysis and perinatal outcome studies 2022
- Altered Expression of Interleukin-18 System mRNA at the Level of Endometrial Myometrial Interface in Women with Adenomyosis 2022
- Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis 2022
- RETROSPECTIVE ANALYSIS OF CHANGING TRENDS IN PRESENTATION AND MANAGEMENT OF ADENOMYOSIS 2022
- Establishment of a Novel Mouse Model of Adenomyosis Suitable for Longitudinal and Quantitative Analysis and Perinatal Outcome Studies 2022
- Classifications of Adenomyosis and Correlation of Phenotypes in Imaging and Histopathology to Clinical Outcomes: a Review 2022
- Cardiometabolic profiles in women with adenomyosis 2022
- Benign gynecologic lesions 2021
- The Pathogenesis of Adenomyosis 2021
- The myometrial‐cervical ratio (MCR): Assessing the diagnostic accuracy of a novel ultrasound measurement in the diagnosis of adenomyosis 2021
- Proposal for adenomyosis classification based on the endometriosis phenotype 2021
- Investigation of the role of platelets in the aetiopathogenesis of adenomyosis 2021
- Adenomyosis pathogenesis: insights from next-generation sequencing 2021
- Ectopic Endometrium: The Pathologist’s Perspective 2021
- Adenomyosis: Disease, uterine aging process leading to symptoms, or both? 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Diagnosing adenomyosis: an integrated clinical and imaging approach 2020
- Immunological changes associated with adenomyosis: a systematic review 2020
- Epidemiology of Adenomyosis 2020
- Relationship between adenomyosis and endometriosis; Different phenotypes of a single disease? 2020
- CONTROVERSIAL ISSUES OF RADIOLOGIC DIAGNOSIS OF ADENOMYOSIS IN REPRODUCTIVE LOSSES 2019
- A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis 2019
- Classification and Reporting Systems for Adenomyosis 2019
- Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens 2018
- Sonographic classification and reporting system for diagnosing adenomyosis 2018
- Treatment options and reproductive outcome for adenomyosis-associated infertility 2017
- Uterine Stem Cells and Their Future Therapeutic Potential in Regenerative Medicine 2017
- Myofibroblasts Are Evidence of Chronic Tissue Microtrauma at the Endometrial-Myometrial Junctional Zone in Uteri With Adenomyosis 2017
- Effects of Jiawei Shaoyao‐Gancao Decoction and Its Drug‐Containing Serum on Proliferation, Apoptosis, and Ultrastructure of Human Adenomyosis Foci Cells 2017
- Repeatability of Junctional Zone Measurements Using 3‐Dimensional Transvaginal Sonography in Healthy Fertile Women 2016
- Down-regulation of tumor suppressor PDCD4 expression in endometrium of adenomyosis patients 2016
- The Pathophysiology of Adenomyosis 2015
- The Incidence and Clinical Significance of Adenomyosis 2015
- Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition 2015
- The Role of the Myometrium in Adenomyosis 2015
- Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells. 2015
- Adenomyosis 2014
- L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner. 2014
Source provenance
- europepmc
- last seen: 2026-08-04T06:16:37.499272+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:36.046895+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00